Literature DB >> 35586680

Presentation and management of rare saccular superior mesenteric artery trunk and branch aneurysms.

Sunny Sahajwani1, Besher Tolaymat2, Ali Khalifeh3, Motahar Hosseini1, Rafael Santini-Dominguez1, David Blitzer4, Rajabrata Sarkar1, Shahab Toursavadkohi1.   

Abstract

Superior mesenteric artery (SMA) aneurysm is caused by degeneration of the visceral arteries. Although a rarely encountered entity, it requires timely management owing to the high mortality rate associated with rupture, particularly when the aneurysm is saccular in nature. As such, urgent treatment is generally indicated. We present five cases of SMA aneurysm arising from the main trunk or branches of the SMA.
© 2020 The Authors.

Entities:  

Keywords:  Aneurysm; Revascularization; Rupture; Superior mesenteric artery

Year:  2020        PMID: 35586680      PMCID: PMC9108514          DOI: 10.1016/j.jvscit.2020.07.011

Source DB:  PubMed          Journal:  J Vasc Surg Cases Innov Tech        ISSN: 2468-4287


Visceral artery aneurysms are rarely encountered, with an incidence of 0.1% to 2.0%. Of this group, superior mesenteric artery (SMA) aneurysms (SMAA) account for just 5.5%, third in line behind splenic and hepatic artery aneurysms. Most SMAAs present as incidental findings; however, some patients have reported a combination of nausea, weight loss, malaise, pyrexia, and abdominal pain. A combination of a low index of suspicion, stemming from rarity of the disease, and nonspecific symptoms usually leads to a delay in diagnosis, which can have lethal consequences as the reported mortality for a ruptured SMAA is 38% to 50%. Because a subset of SMAAs are mycotic in origin we expect clinicians to increasingly encounter SMAAs with the increase in intravenous drug abuse (IVDA) in relation to infective endocarditis. Therapy is mainly divided into open surgical approaches, including aneurysmectomy with or without vascular reconstruction, although success with endovascular techniques has been reported, with long-term antibiotic therapy in cases of mycotic aneurysms. In all scenarios, end-organ resection is considered if perfusion to the small or large intestines is thought to be jeopardized. Only recently, the Society of Vascular Surgery released guidelines pertaining to the diagnosis, management, and follow-up of visceral arterial aneurysms, including SMAA. We aim to present a single institution's experience with aneurysms of the SMA or its branches. All patients consented for publication.

Methods

Medical records and imaging studies from a single academic medical center from January 2016 to January 2019 were retrospectively reviewed. We describe the presentation, operative management, postoperative outcomes, and follow-up from a series of five patients with aneurysms, four originating from a branch of the SMA, and the fifth from the main trunk of the SMA (Tables I and II).
Table I

Clinical characteristics

Case No.AgeSexPertinent historySMA branch pointPresentationSize, cm
175FemaleNoneYesIncidental finding3.5
254FemaleNoneYesSymptomatic (back pain)1.5
374FemaleEndocarditisYesSymptomatic (RUQ pain)1.2
470MaleIVDAYesIncidental finding2
561FemaleNoneYesRupture1.5

IVDA, Intravenous drug abuse; RUQ, right upper quadrant; SMA, superior mesenteric artery.

Table II

Interventions and outcomes

Case No.RepairBowel resectionLong-term antibioticsOutcome
1PTFE aorto-common hepatic artery bypass and aneurysmectomyNoNoPatient bypass >30 days
2Aneurysmectomy and bifurcated reversed GSV graftNoNoPatient bypass >30 days
3AneurysmectomyNoYesNone
4AneurysmectomyNoYesNone
5AneurysmectomyNoNoMortality

GSV, Greater saphenous vein; PTFE, polytetrafluoroethylene.

Clinical characteristics IVDA, Intravenous drug abuse; RUQ, right upper quadrant; SMA, superior mesenteric artery. Interventions and outcomes GSV, Greater saphenous vein; PTFE, polytetrafluoroethylene.

Case reports

Case 1

A 75-year-old woman with lower back pain underwent a computed tomography (CT) scan with IV contrast to evaluate for lumbar spine disease. She had no history of IVDA, endocarditis, degenerative disease, aortic or visceral aneurysms, or peripheral arterial disease. An incidental finding of a 2.6 × 3.5 cm saccular aneurysm of the SMA arising from a proximal branch of the SMA was noted (Fig 1). The patient was taken electively for laparotomy. On exploration, it was found that the SMAA was compressing the celiac artery, which seemed to be chronically occluded. Because the SMA was providing significant collateral flow to the hepatic and splenic territories as revealed on angiography 1 month prior, we opted to preserve flow with vascular reconstruction. The aneurysm was significantly adherent to the surrounding tissue, including the duodenum, and careful mobilization of the duodenum away from the aneurysm was performed. She underwent aneurysmectomy, and, because clinical suspicion for an infectious etiology was low, an 8-mm prosthetic polytetrafluoroethylene graft was used to create an aorto-common hepatic artery bypass. Approximately 20 to 30 minutes after the anastomosis, the bowel was reassessed and found to have a pink color, peristalsis, and a palpable pulse and Doppler signal at the mesenteric border. The patient's recovery was uncomplicated. Intraoperative cultures were negative. Two weeks postoperatively, a duplex mesenteric study showed a patent aortohepatic artery bypass. She continues to be followed in our clinic 2 years later, with further duplex scans showing both bypass and SMA patency.
Fig 1

A 3.2-cm superior mesenteric artery (SMA) aneurysm from a branch of the proximal SMA.

A 3.2-cm superior mesenteric artery (SMA) aneurysm from a branch of the proximal SMA.

Case 2

A 54-year-old woman presented with lower back pain and underwent a CT scan of the lumbar spine with IV contrast and was found to have a 1.5 cm aneurysm arising 4 cm distal to the take-off of the SMA. She had no risk factors for SMAA in her history. Of note, she did undergo a laparoscopic tubal ligation 13 years prior. Although speculative, an injury at that time could have resulted in visceral arterial degeneration and aneurysm formation. The aneurysm had a worrisome configuration with a saccular component. Although the aneurysm involved the main trunk, two major branches of the SMA originated directly from the aneurysm. Reconstruction was performed with a bifurcated vein bypass graft using reversed great saphenous vein (Fig 2). Intraoperative cultures were negative, yielding a diagnosis of cryptogenic SMAA. Postoperative surveillance CT angiography (CTA) showed patent vein bypass graft at 30 days, and she reported resolution of her lower back pain on follow-up.
Fig 2

Proximal superior mesenteric artery (SMA) aneurysm at a branch point repaired with an interposition saphenous vein graft.

Proximal superior mesenteric artery (SMA) aneurysm at a branch point repaired with an interposition saphenous vein graft.

Case 3

A 74-year-old woman was admitted with right upper quadrant abdominal pain and underwent CTA of the abdomen and pelvis. A 1.2 cm saccular aneurysm at the branchpoint of the SMA and ileocolic artery was identified (Fig 3). She had a history significant for Staphylococcus epidermidis mitral valve endocarditis treated with open mitral valve repair less than 1 month before presentation. Blood cultures at time of admission were positive for S epidermidis. She admitted to recent weight loss and decreased appetite, although this had been previously attributed to the postoperative recovery after her mitral valve repair. On laparotomy, an aneurysmal ileal branch off of the SMA was easily identified with cephalad retraction of the small intestines. She underwent aneurysmectomy, isolating the ileal branch proximally and distally, while ligating feeding vessels. Intraoperative cultures grew S epidermidis. The acute care surgery was present for intraoperative observation at initial laparotomy and again before closure of the abdomen and based on the appearance of the bowel as well as its rapid peristalsis, determined there was no need for bowel resection nor second-look laparotomy. The patient recovered and was discharged on a 6-week course of daptomycin.
Fig 3

Computed tomography (CT) imaging showing saccular aneurysm of the ileocolic branch of the superior mesenteric artery (SMA).

Computed tomography (CT) imaging showing saccular aneurysm of the ileocolic branch of the superior mesenteric artery (SMA).

Case 4

A 70-year-old man presented to the emergency department complaining of left-sided chest pain. He had a history of IVDA, cocaine abuse, and multiple episodes of genital chlamydia and gonorrhea infections over the past year. At the time of presentation, the patient had no identifiable infection nor leukocytosis, and had negative blood cultures. CTA of the chest and abdomen showed penetrating aortic ulcers of the descending thoracic aorta without rupture as well as an incidental, 2-cm saccular aneurysm of the SMA approximately 6 cm from the origin of the SMA. Aneurysmectomy was performed without violating the main SMA trunk. Revascularization and end-organ resection were not required. The aneurysm was opened off the surgical field and yielded purulent fluid. Postoperatively, cultures of this fluid did not isolate microorganisms. The patient was treated with IV antibiotics for 4 weeks, then underwent thoracic endovascular aortic repair to treat the penetrating ulcers of his descending thoracic aorta. The patient completed an additional 2-week course of IV antibiotic therapy upon discharge. Mesenteric duplex ultrasound examination was performed 14 months postoperatively showed healthy celiac and SMA vasculature.

Case 5

A 61-year old female patient presented to an outside facility with severe abdominal pain. She became hypotensive and unresponsive in the emergency department resulting in intubation. The patient was transferred to our tertiary care facility and was stabilized with volume and blood product resuscitation in the intensive care unit. Her past medical history was insignificant for trauma, infections, or arterial disease that would predispose her to SMAA formation. CT imaging demonstrated a contained rupture from a 1.5 cm-SMAA associated with a large retroperitoneal hematoma medial to the left kidney. On emergent laparotomy, it was discovered she had a large hematoma of the transverse mesocolon. The inflow to the SMA was isolated at the base of the transverse mesocolon. We found a proximal branch off the SMA that was feeding the aneurysm. An Endo-stapler was used to fire a vascular, 1-mm staple height, cartridge to seal in the in-flow, and then outgoing branches were dissected and ligated. The aneurysm was resected. Again, there was no need for revascularization or end-organ resection. Postoperatively, the patient was unable to overcome the insult from the initial hemorrhagic event. Repeat CTA did not show evidence for ongoing hemorrhage, and she underwent emergent bedside laparotomy in the surgical intensive care unit, which did not reveal ischemic nor necrotic bowel. She remained coagulopathic, acidotic, and died from multiorgan failure.

Discussion

Given the rare and often emergent presentation of SMAA, the primary etiology aneurysm formation has been a topic of debate. Although a primary mycotic etiology was described as the most common presentation for SMAAs previously, more recent studies have suggested atherosclerosis to be the most common causative factor. However, in up to 50% to 80% of cases, there is no identifiable cause, categorizing these SMAAs because cryptogenic in origin., Similarly, three of our five cases did not have an identifiable etiology and were diagnosed as cryptogenic aneurysms. The pathogenesis and natural course of aneurysmal processes are well-studied in aortic aneurysms, but have yet to be elucidated in the context of the SMA specifically. Hyperdynamic flow through the SMA in the presence of other visceral artery occlusions can cause aneurysm formation. Only the first case had an occluded celiac from compression by the SMAA. In the remaining cases, no visceral artery occlusion was found to suggest this etiology. Aneurysmal degeneration of atherosclerotic disease may account for cryptogenic SMAAs. Samples were sent for histologic review in four of our cases; two cases (cases 3 and 5) were classified as infectious pseudoaneurysms, one cases (case 2) as pseudoaneurysm with intimal thickening and adventitial scarring, and the last (case 1) with no definitive diagnosis, although significant atherosclerosis was noted. No case had histologic evidence of dissection, a connective tissue disorder, or vasculitis. SMAAs occur most commonly in adults and have a male predominance; however, in our short series, four of the five cases were female. Although not represented in our series, case reports in relatively younger patients have pointed to more rare etiologies of aneurysm formation in the SMA including rheumatic endocarditis (with superimposed subacute bacterial endocarditis), Brucella endocarditis, and suppurative adenitis in a patient with no other clear source of septic emboli. Traumatic SMAA has also been reported. Less common etiologies include Behcet's disease, Takayasu's arteritis, segmental arterial mediolysis,, Ehlers-Danlos syndrome, and fibromuscular dysplasia. Just as in adults, the pediatric population can also be affected by mycotic aneurysms, although rarely reported. Although a SMAA may present with preceding weight loss, decreased appetite, or as a sequelae of chronic inflammation such as pancreatitis, only one patient (case 3) in our series had such symptoms (reporting weight loss in the 2-3 months before aneurysmectomy). CTA is the primary modality for diagnosis, because it allows for simultaneous evaluation of the aneurysm as well as the other mesenteric vessels. Mycotic aneurysms are most often caused by local degeneration of the arterial wall secondary to infection. Mycotic pathogenesis can be initiated by (a) contiguous infection, (b) hematogenous spread, (c) septic emboli, typically in the context of infective endocarditis, or (d) direct, contaminated arterial puncture, such as in the setting of nonsterile hospital conditions or IVDA., Definitive treatment of the mycotic SMAA must address the aneurysm as well as treat with long term antibiotics if infection is found. A complete workup and effort to identify occult infection should be undertaken so as to not miss a distant source of seeding., It is for this reason it is our practice to approach SMAAs with open surgical therapy. Although endovascular therapies have been increasingly reported, we find this to be suboptimal management without definitively ruling out infection with direct cultures or operative examination. In our series, two of our patients had infective etiology and required long-term antibiotics. In case 4, the patient presented without leukocytosis, had negative blood cultures, and negative intraoperative cultures. However, with a history of genital infections and IVDA our suspicion was high. Upon operative exploration, an inflamed and purulent aneurysm sac was discovered, resulting in treatment with long-term antibiotics. According to the recently published Society of Vascular Surgery guidelines, repair is recommended for all SMAAs, whether a true aneurysm or a pseudoaneurysm. Indeed, this pathophysiology has not been well-studied, and yet the outcomes of ruptured aneurysms are often severe. In this context and in line with these society recommendations, our department will recommend operation on a SMAA regardless of size, in the appropriate clinical context. Several treatment strategies have been reported for SMAA. Open surgical approaches have been the mainstay of treatment of SMAAs. Endovascular techniques including stents and coil embolization have been reported for cases with23, 24, 25, 26, 27 and without, rupture. Oechsle et al used a percutaneous approach, injecting thrombin directly into the lumen, under ultrasound guidance, to achieve thrombotic occlusion of the aneurysm sac. Zilun et al published a series of 16 patients in which the majority of patients were electively treated with overlapping bare metal stents. The majority of these patients did well; however, two patients died, in one case owing to stent thrombosis and in another owing to delayed rupture of the SMAA. A recent systematic review of visceral artery aneurysms suggests mortality is actually similar between endovascular and open techniques. There may be a role for endovascular treatments in patients with multiple medical comorbidities and optimal lesions, and indeed, the recently published Society of Vascular Surgery guidelines recommend an “endovascular-first approach to all SMAAs if anatomically feasible.” These guidelines further suggest, however, that an SMAA that extends beyond the proximal few centimeters of the ostium includes important branches that must be maintained and, as such, open surgery is recommended more strongly. Because this was the case in our experience, to avoid endovascular coverage of these branches, we opted for open repair. The majority of SMAAs are saccular aneurysms, have an increased risk of rupture, and are associated with mycotic etiology. Our practice is to treat each case definitively with resection and long-term antibiotics where infection is confirmed. Our approach has been via laparotomy to maximize our ability to gain vascular control, although there have been reports of laparoscopic resections of SMAAs. Direct surgical approaches also allow the opportunity to address end organ perfusion simultaneously. Revascularization after aneurysmectomy is an important consideration in every case. The statuses of the celiac axis and inferior mesenteric artery are preoperatively evaluated with CTA in each case. Intraoperatively, about 20 to 30 minutes after repair of the aneurysm, the bowel is reassessed for its color and a palpable pulse and/or a Doppler signal at the mesenteric border to help determine whether revascularization is warranted. Other adjuncts, such as fluorescein injection and evaluation with a Wood's lamp, can be considered as well. Rupture is the feared complication of SMAA. An accurate estimate of the incidence of rupture is difficult, given the predominance of single case reports in the literature. In the largest study of 21 cases, 8 (38%) presented with rupture; the operative mortality rate of these ruptured cases was 37.5%. In our institutional case series, we had a 100% mortality owing to ruptured SMAA. There is a 15% reported mortality for surgical intervention of nonruptured SMAAs. In our experience, patients we treated for SMAA who were not ruptured had a 0% mortality and no long-term morbidity owing to our treatment. Our approach to follow-up involves a mesenteric duplex study and initial clinic visit within 1 month, and repeated ultrasound evaluation and clinical assessment afterwards. Using a high index of suspicion, patients are questioned about diet, weight loss, food fear, nausea, abdominal pain, and any positive finding, especially if in the context of a borderline or positive mesenteric duplex, warrants a CTA and further workup. We described multiple saccular aneurysms involving the branches or main trunk of the SMA that were successfully treated with resection. When aneurysms involve branches of the main SMA, in our experience the need for reconstruction was limited, because there is significant collateralization through parallel circuits from the celiac, inferior mesenteric artery, and from the SMA itself. The limited role of resection in this scenario is encouraged by our case series; we did not need to resect bowel in any case that involved only aneurysmectomy. At follow-up, all survivors have good bowel function and recovered fully from the surgical intervention.

Conclusions

SMAAs are a rare disease that require urgent management to avoid the often fatal consequences of rupture. Aneurysmectomy, with or without reconstruction, can treat the majority of SMAAs with a good outcome, whether they involve the main trunk or the branches. As the experience in identifying SMAAs, diagnosing the etiology, and providing optimal treatment grows, devastating outcomes from aneurysm rupture may be better prevented.
  31 in total

1.  Superior mesenteric artery aneurysm in a 9-year-old boy with classical Ehlers-Danlos syndrome.

Authors:  K de Leeuw; J F Goorhuis; I F J Tielliu; S Symoens; F Malfait; A de Paepe; J P van Tintelen; J B F Hulscher
Journal:  Am J Med Genet A       Date:  2012-02-02       Impact factor: 2.802

2.  Percutaneous treatment of a ruptured superior mesenteric artery aneurysm in a child.

Authors:  Susanne Oechsle; Kurt Vollert; Wolfgang Buecklein; Wolfgang Michl; Frank W Roemer
Journal:  Pediatr Radiol       Date:  2006-01-24

Review 3.  Uncommon splanchnic artery aneurysms: pancreaticoduodenal, gastroduodenal, superior mesenteric, inferior mesenteric, and colic.

Authors:  C J Shanley; N L Shah; L M Messina
Journal:  Ann Vasc Surg       Date:  1996-09       Impact factor: 1.466

4.  Infected aneurysm: current management.

Authors:  Young-Wook Kim
Journal:  Ann Vasc Dis       Date:  2010-07-21

5.  Endovascular stent--graft repair of a symptomatic superior mesenteric artery aneurysm.

Authors:  Michael Schweigert; Ralf Adamus; Rudolf J Stadlhuber; Hubert J Stein
Journal:  Ann Vasc Surg       Date:  2011-05-28       Impact factor: 1.466

6.  Superior mesenteric artery aneurysm stent graft.

Authors:  R Drescher; O Köster; T von Rothenburg
Journal:  Abdom Imaging       Date:  2006 Jan-Feb

Review 7.  Brucella endocarditis complicated with a mycotic aneurysm of the superior mesenteric artery: a case report.

Authors:  Ali Riza Erbay; Hasan Turhan; Mehmet Dogan; Sakine Erbasi; Kerim Cagli; Irfan Sabah
Journal:  Int J Cardiol       Date:  2004-02       Impact factor: 4.164

Review 8.  Ruptured and unruptured mycotic superior mesenteric artery aneurysms.

Authors:  Gaurav Sharma; Marcus E Semel; Edward A McGillicuddy; Karen J Ho; Matthew T Menard; Jonathan D Gates
Journal:  Ann Vasc Surg       Date:  2014-07-10       Impact factor: 1.466

9.  Massive bleeding from a ruptured superior mesenteric artery aneurysm duodenum.

Authors:  R D Maloney; T F Nealon; E A Roberts
Journal:  Arch Surg       Date:  1976-03

10.  Open repair of superior mesenteric artery mycotic aneurysm in an adolescent girl.

Authors:  Jean Marie Ruddy; Thomas F Dodson; Yazan Duwayri
Journal:  Ann Vasc Surg       Date:  2013-10-31       Impact factor: 1.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.